Literature DB >> 26648634

Antiplatelet drugs and the smokers' paradox.

Colin Mendelsohn1.   

Abstract

Year:  2015        PMID： 26648634      PMCID： PMC4653984          DOI： 10.18773/austprescr.2015.044

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  8 in total

Review 1.  Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis.

Authors:  Christopher Cao; Praveen Indraratna; Su C Ang; Con Manganas; John Park; Paul G Bannon; Tristan D Yan
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-23       Impact factor: 5.209

2.  Smoking and prasugrel.

Authors:  Yicong Ye; Hongzhi Xie; Xiliang Zhao; Shuyang Zhang
Journal:  Int J Cardiol       Date:  2013-02-06       Impact factor: 4.164

Review 3.  Cigarette smoking and clopidogrel interaction.

Authors:  Kristopher J Swiger; Omair Yousuf; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 4.  Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors.

Authors:  Paul A Gurbel; Brian A Baker; William L Bailey; Kevin P Bliden; Udaya S Tantry
Journal:  Thromb Haemost       Date:  2014-02-20       Impact factor: 5.249

5.  The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study.

Authors:  Paul A Gurbel; Kevin P Bliden; Douglas K Logan; Dean J Kereiakes; Kenneth C Lasseter; Alex White; Dominick J Angiolillo; Thomas D Nolin; Jen-Fue Maa; William L Bailey; Joseph A Jakubowski; Clement K Ojeh; Young-Hoon Jeong; Udaya S Tantry; Brian A Baker
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

6.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

Authors:  Jochem W van Werkum; Antonius A Heestermans; A Carla Zomer; Johannes C Kelder; Maarten-Jan Suttorp; Benno J Rensing; Jacques J Koolen; B R Guus Brueren; Jan-Henk E Dambrink; Raymond W Hautvast; Freek W Verheugt; Jurriën M ten Berg
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

7.  Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

Authors:  Jan H Cornel; Richard C Becker; Shaun G Goodman; Steen Husted; Hugo Katus; Anwar Santoso; Gabriel Steg; Robert F Storey; Marius Vintila; Jie L Sun; Jay Horrow; Lars Wallentin; Robert Harrington; Stefan James
Journal:  Am Heart J       Date:  2012-07-26       Impact factor: 4.749

8.  Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison.

Authors:  Joshua J Gagne; Katsiaryana Bykov; Niteesh K Choudhry; Timothy J Toomey; John G Connolly; Jerry Avorn
Journal:  BMJ       Date:  2013-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.